Welcome to OncoDaily Weekly, your all-in-one roundup of this week’s oncology news, policy shifts, scientific advances, leadership moves and insightful stories from January 26 to 31.
This week felt like what oncology progress looks like in real time: global conversations turning into action, policy signals reshaping the runway, and science moving fast enough that the “what’s next” keeps changing mid-week.
Global OncoThon 2026: What a Team Can Build
OncoDaily’s Third Global OncoThon (2026) closed with over 300,000 viewers and 130+ speakers joining from across the world – one of those rare moments where the community doesn’t just talk about impact, it creates it.
In his wrap-up, Dr. Gevorg Tamamyan, Editor-in-Chief of OncoDaily and President of SIOP Asia and POEM Group, captured the core lesson of the marathon: the scale wasn’t luck – it was team power, discipline, and showing up for each other when the mission is bigger than any one person.
World Cancer Day Highlights
Across World Cancer conversations this week, the throughline was simple: people-first care isn’t “soft” – it’s the most practical standard we have. We curated posts not to miss in three parts for you to follow the calls the oncology community had to make that day.
Microsoft for Nonprofits framed “United by Unique” as a call to pair ethical technology with dignity, equity, and human-centered delivery.
This Week OncoDaily was Extra-Busy
OncoDaily served as an official partner on-site at ELLOK 2026, covering the meeting in real time and bringing forward not just the program—but the perspectives, interviews, and takeaways that clinicians actually carry back to practice.
OncoDaily TV released a new episode of Global Health Dialogues with Princess Dina Mired, featuring Dr. Gevorg Tamamyan on global health leadership and oncology priorities – an intimate, systems-level conversation grounded in real-world delivery.
We released the February Issue cover story of OncoDaily Magazine featuring Christopher Clinton Conway, tracing a philanthropy career built on trust – and what it takes to mobilize missions that matter at scale.
We also published the World Health Voices February cover story with Dr. Jigjidsuren Chinburen, Mongolia’s Minister of Health – on building national cancer capacity with honesty, prevention, and the refusal to accept “nothing more to do” as an endpoint.
The AMSTRO 2026 Global Oncology Conference abstracts were live at the OncoDaily Medical Journal, ahead of the Feb 6 -8, 2026 meeting in Dubai – spanning modern radiation oncology practice, innovation, and delivery across diverse settings.
Government and FDA
A new FY26 funding bill passed Congress on Feb 3, 2026, increasing NIH ($47.2B) and NCI ($7.4B) funding and extending Medicare telehealth flexibilities through Dec 31, 2027 – a meaningful policy tailwind for cancer research and access.
On the FDA front, pelareorep received Fast Track for 2L KRAS-mutant MSS metastatic colorectal cancer in combination with bevacizumab + FOLFIRI.
A supplemental application for datopotamab deruxtecan (Dato-DXd) earned Priority Review as 1L therapy for unresectable/metastatic TNBC in patients ineligible for PD-1/PD-L1 immunotherapy, with a decision expected in Q2 2026.
And zenocutuzumab-zbco (BIZENGRI) secured Orphan Drug Designation for NRG1 fusion–positive unresectable/metastatic cholangiocarcinoma, reinforcing the momentum behind biomarker-defined GI oncology.
Biotech: IPO momentum and MRD regulation
Biotech markets showed fresh appetite as Eikon Therapeutics raised $381M in an IPO, backing a live-cell imaging platform aimed at accelerating oncology drug discovery.
In diagnostics, Natera filed an FDA PMA for Signatera CDx to detect MRD in muscle-invasive bladder cancer, positioned as a companion diagnostic to identify patients who may benefit from atezolizumab.
Valentine’s: Making Space for the Human Part
OncoDaily opened a private, non-public space for people affected by cancer to write a Valentine’s letter – less about perfect words, more about truth, love, and what illness changes (and doesn’t erase) which will be published anonymously for one message to reach many who need to read it.
We Also Offer Music
We closed the week with something uniquely OncoDaily: Dr. Elen Baloyan, Managing Editor of OncoDaily and Editor-in-Chief of OncoDaily Magazine, released her first mini-EP (“mind”), a 6-song project that hopes to resonate with those facing hard times in life.
